Patent and Know-How License Agreement Sample Contracts
ANDPatent and Know-How License Agreement • January 18th, 2006 • Omrix Biopharmaceuticals, Inc. • London
Contract Type FiledJanuary 18th, 2006 Company Jurisdiction
EX-10.9 9 d381653dex109.htm FORM OF PATENT AND KNOW-HOW LICENSE AGREEMENT (PFIZER AS LICENSOR) FORM OF PATENT AND KNOW-HOW LICENSE AGREEMENT (PFIZER AS LICENSOR)Patent and Know-How License Agreement • May 5th, 2020 • New York
Contract Type FiledMay 5th, 2020 JurisdictionThis PATENT AND KNOW-HOW LICENSE AGREEMENT (the “Agreement”) is made effective as of [—] (the “Effective Date”), by and between Pfizer Inc., a Delaware corporation having its principal place of business at 235 E. 42nd Street, New York, New York 10017 (“Pfizer”) and Zoetis Inc., a Delaware corporation having its principal place of business at 235 E. 42nd Street, New York, New York 10017 (the “Company”). Pfizer and the Company are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
EX-10.7 12 d500108dex107.htm EX-10.7Patent and Know-How License Agreement • May 5th, 2020
Contract Type FiledMay 5th, 2020CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[***]”. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED.
PATENT AND KNOW HOW LICENCE AGREEMENTPatent and Know How License Agreement • August 31st, 2023
Contract Type FiledAugust 31st, 2023MEDICINES PATENT POOL (“MPP”), a Swiss foundation located at 7 Rue de Varembé, 1202 Geneva, Switzerland, acting as implementing partner of the World Health Organisation (“WHO”) COVID-19 Technology Access Pool initiative (“WHO C-TAP”)
Patent and Know-How License AgreementPatent and Know-How License Agreement • May 28th, 2021 • Miromatrix Medical Inc. • Biological products, (no disgnostic substances) • Minnesota
Contract Type FiledMay 28th, 2021 Company Industry JurisdictionThis Patent and Know-How License Agreement ("Agreement"), dated as of June 30, 2019 (the "Effective Date"), is by and between Miromatrix Medical Inc., a Delaware corporation ("Licensor"), and Reprise Biomedical, Inc., a Minnesota corporation ("Licensee") (collectively, the "Parties" or each, individually, a "Party").
PATENT AND KNOW-HOW LICENSE AGREEMENT (THE COMPANY AS LICENSOR)Patent and Know-How License Agreement • March 28th, 2013 • Zoetis Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 28th, 2013 Company Industry JurisdictionTHIS PATENT AND KNOW-HOW LICENSE AGREEMENT (the "Agreement") is made effective as of February 6, 2013 (the "Effective Date"), by and between Pfizer Inc., a Delaware corporation having its principal place of business at 235 E. 42nd Street, New York, New York 10017 ("Pfizer") and Zoetis Inc., a Delaware corporation having its principal place of business at 5 Giralda Farms, Madison, NJ 07940 (the "Company"). Pfizer and the Company are sometimes referred to herein individually as a "Party" and collectively as the "Parties."
EX-4.L 5 y98596exv4wl.htm PATENT AND KNOW-HOW LICENSE AGREEMENT PATENT AND KNOW-HOW LICENSE AGREEMENT THIS AGREEMENT, effective the 5 day of August, 1995, is made by and between:Patent and Know-How License Agreement • May 5th, 2020 • Ontario
Contract Type FiledMay 5th, 2020 JurisdictionSHERRITT INC., an Ontario Corporation, having a business office at Fort Saskatchewan, Alberta, Canada (hereinafter called “Sherritt”);
Amendment No. 2 to Patent and Know-How License AgreementPatent and Know-How License Agreement • May 28th, 2021 • Miromatrix Medical Inc. • Biological products, (no disgnostic substances) • Minnesota
Contract Type FiledMay 28th, 2021 Company Industry JurisdictionThis Amendment No. 2 to the Patent and Know-How License Agreement (this “Amendment”), amending that certain Patent and Know-How License Agreement (the “License Agreement”), dated as of June 30, 2019, by and between Miromatrix Medical Inc., a Delaware corporation (“Licensor”), and Reprise Biomedical, Inc., a Minnesota corporation (“Licensee”), is made as of February 22, 2021.
AMENDED AND RESTATED PATENT AND KNOW HOW LICENSE AGREEMENTPatent and Know How License Agreement • December 5th, 2022 • Coya Therapeutics, Inc. • Pharmaceutical preparations • Texas
Contract Type FiledDecember 5th, 2022 Company Industry JurisdictionTHIS AMENDED AND RESTATED PATENT AND KNOW HOW LICENSE AGREEMENT (this “Agreement”) is made effective as of October 6, 2020 (the “Effective Date”) by and between The Methodist Hospital, a Texas non-profit corporation (“METHODIST”), and Coya Therapeutics, Inc. (“LICENSEE”), a Delaware corporation (as successor in interest to Nicoya Health, Inc.).
NOVAN PATENT AND KNOW-HOW LICENSE AGREEMENTPatent and Know-How License Agreement • August 24th, 2016 • Novan, Inc. • Pharmaceutical preparations • North Carolina
Contract Type FiledAugust 24th, 2016 Company Industry JurisdictionTHIS NOVAN PATENT AND KNOW-HOW LICENSE AGREEMENT (this “Agreement”) is made as of December 29, 2015 (the “Effective Date”) by and between Novan, Inc., a Delaware corporation with a principal place of business at 4222 Emperor Boulevard, Suite 200, Durham, NC 27703 (“Novan”), and KNOW Bio, LLC, a North Carolina limited liability company with a principal place of business at 627 Davis Drive, Suite 400, Morrisville, NC 27560 (“Licensee”). Novan and Licensee may each be referred to as a “Party,” and together as the “Parties.”
Amendment No. 1 to Patent and Know-How License AgreementPatent and Know-How License Agreement • May 28th, 2021 • Miromatrix Medical Inc. • Biological products, (no disgnostic substances) • Minnesota
Contract Type FiledMay 28th, 2021 Company Industry JurisdictionThis Amendment No. 1 to the Patent and Know-How License Agreement (this “Amendment”), amending that certain Patent and Know-How License Agreement (the “License Agreement”), dated as of June 30, 2019, by and between Miromatrix Medical Inc., a Delaware corporation (“Licensor”), and Reprise Biomedical, Inc., a Minnesota corporation (“Licensee”), is made as of October 3, 2019.
PATENT AND KNOW-HOW LICENSE AGREEMENTPatent and Know-How License Agreement • January 19th, 2021 • Decipher Biosciences, Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledJanuary 19th, 2021 Company Industry JurisdictionThis Patent and Know-How License Agreement (“Agreement”) is entered into as of February 1, 2013 (“Effective Date”) by and between Mayo Foundation for Medical Education and Research, a Minnesota charitable corporation, located at 200 First Street SW, Rochester, Minnesota 55905-0001 (“Mayo”), and GenomeDx Biosciences, Inc., a corporation having its principal place of business at 311 Water Street, 4th Floor, Vancouver, B.C., Canada, V6B 1B8 (“Company”).
PATENT AND KNOW HOW LICENSE AGREEMENT LSU FILEPatent and Know How License Agreement • February 20th, 2015 • Louisiana
Contract Type FiledFebruary 20th, 2015 Jurisdiction, with offices located at ("LICENSEE"), and the Board of Supervisors of Louisiana State University and Agricultural and Mechanical College, a public constitutional corporation, organized and existing under the laws of the State of Louisiana ("LSU"). LICENSEE and LSU agree as follows:
PATENT AND KNOW-HOW LICENSE AGREEMENT Between PIERRE FABRE MEDICAMENT S.A. and NOVACEA, Inc. Dated July 19, 2005Patent and Know-How License Agreement • May 2nd, 2006 • Novacea Inc • Pharmaceutical preparations • New York
Contract Type FiledMay 2nd, 2006 Company Industry JurisdictionTHIS PATENT AND KNOW-HOW LICENSE AGREEMENT (the “Agreement”) is executed on July 19, 2005 (the “Effective Date”) by and between PIERRE FABRE MEDICAMENT S.A., a corporation organized under the laws of France with headquarters at 45, place Abel-Gance, 921000 BOULOGNE, FRANCE (“PIERRE FABRE”) and NOVACEA, INC., a Delaware corporation with a principal place of business at 601 Gateway Boulevard, Suite 800, SOUTH SAN FRANCISCO, CALIFORNIA 94080, U.S.A. (“NOVACEA”).
FORM OF PATENT AND KNOW-HOW LICENSE AGREEMENTPatent and Know-How License Agreement • May 12th, 2023 • C-Bond Systems, Inc • Investors, nec • Texas
Contract Type FiledMay 12th, 2023 Company Industry JurisdictionThis Patent and Know-how License Agreement (“Agreement”), dated as of May 8, 2023 (the “Effective Date”), is by and between C-Bond Systems LLC, a Texas limited liability company, with offices located at 6035 South Loop East, Houston, TX 77033 (“Licensor”) and Apex Protect GPS, LLC, a limited liability company organized pursuant to the laws of the State of Texas, with offices located at 5802 N. Navarro, Victoria, TX 77904 (“Licensee”).
Patent and Know How License Agreement between Kimberly-Clark Worldwide, Inc. and Avent, Inc. Made as of the 30th day of October, 2014Patent and Know How License Agreement • November 4th, 2014 • Halyard Health, Inc. • Orthopedic, prosthetic & surgical appliances & supplies • Delaware
Contract Type FiledNovember 4th, 2014 Company Industry JurisdictionTHIS AGREEMENT, effective as of the 30th day of October, 2014, by and between KIMBERLY-CLARK WORLDWIDE, INC., a Delaware corporation (“KCWW” or “Licensor”), and AVENT, INC., a Delaware corporation (“Avent” or “Licensee”).
Certain identified information has been omitted from this exhibit because it is both (i) not material and (ii) would likely cause competitive harm to the Registrant if publicly disclosed. Such omitted information is indicated by brackets...Patent and Know-How License Agreement • November 9th, 2020 • Sorrento Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledNovember 9th, 2020 Company Industry JurisdictionThis Patent and Know-How License Agreement (“Agreement”) is by and between Mayo Foundation for Medical Education and Research, a Minnesota charitable corporation, located at 200 First Street SW, Rochester, Minnesota 55905-0001 (“MAYO”), and Sorrento Therapeutics, Inc. (“SORRENTO”), a for-profit corporation, having a place of business at4955 Directors Place, San Diego, CA 92121, each a “Party”, and collectively “Parties”.
PATENT AND KNOW-HOW LICENSE AGREEMENT No. 07554F33 AMENDMENT No. 3Patent and Know-How License Agreement • September 13th, 2024 • Bluebird Bio, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledSeptember 13th, 2024 Company IndustryINSERM-TRANSFERT SA, "Societe Anonyme a Dίrectoire et Conseίl de Surveίllance", a limited company organized under the laws of France, with share capital of €9,573,470, whose registered headquarters are located at 7 rue Watt, 75013 Paris, France, SIRET Νο. 434 033 619 00025 business (ΑΡΕ) code 7219Ζ, Paris Trade and Companies Registry Νο. Β 434 033 619, represented by its Chairman of the Management Board, Mrs. Pascale Auge,
Patent and Know How License Agreement between Kimberly-Clark Worldwide, Inc. and Avent, Inc. Made as of the day of , 2014Patent and Know How License Agreement • September 22nd, 2014 • Halyard Health, Inc. • Orthopedic, prosthetic & surgical appliances & supplies • Delaware
Contract Type FiledSeptember 22nd, 2014 Company Industry JurisdictionTHIS AGREEMENT, effective as of the day of , 2014, by and between KIMBERLY-CLARK WORLDWIDE, INC., a Delaware corporation (“KCWW” or “Licensor”), and AVENT, INC., a Delaware corporation (“Avent” or “Licensee”).
Patent and Know How License Agreement Between Air Assist LLC and The Procter & Gamble CompanyPatent and Know How License Agreement • January 26th, 2024 • Learn SPAC HoldCo, Inc. • Ohio
Contract Type FiledJanuary 26th, 2024 Company JurisdictionThis license agreement, effective and binding as of the last date of signing of this agreement (“EFFECTIVE DATE”), is between [Air Assist LLC], a Delaware limited liability company and AFFILIATES (collectively, “LICENSEE”); and The Procter & Gamble Company, an Ohio corporation and AFFILIATES (collectively, “OWNER”).
PATENT AND KNOW-HOW LICENSE AGREEMENT No 07554F33 AMENDMENT No 4Patent and Know-How License Agreement • September 13th, 2024 • Bluebird Bio, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledSeptember 13th, 2024 Company IndustryINSERM-TRANSFERT SA, "Societe Anonyme a Directoire et Conseil de Serveillance'', a limited company organized under the laws of France, with share capital of €9,573,470, whose registered headquarters are located at 7 rue Watt, 75013 Paris, France, SIRET No. 434 033 619 00025 business (APE) code 72192, Paris Trade and Companies Registry No. B 434 033 619, represented by its Chairman of the Management Board, Mrs. Pascale Auge,
PATENT AND KNOW-HOW LICENSE AGREEMENTPatent and Know-How License Agreement • April 6th, 2010 • Nexx Systems Inc • Semiconductors & related devices • Massachusetts
Contract Type FiledApril 6th, 2010 Company Industry JurisdictionThis AGREEMENT dated as of August 7, 2001 made by and between Applied Science and Technology, Inc., a Delaware corporation having a principal place of business at 90 Industrial Way, Wilmington, Massachusetts, 01887 (“AST”) and ASTeX PlasmaQuest Inc., a corporation of Texas having a principal place of business at 12024 Forestgate Drive, Dallas Texas 75243 (“PlasmaQuest”) (AST and PlasmaQuest are collectively referred to as “Licensors”), on the one hand, and NEXX System LLC, a Delaware limited liability company corporation having its principal place of business at 90 Industrial Way, Wilmington, Massachusetts 01887-4610 (“NEXX”), on the other hand.
PATENT AND KNOW-HOW LICENSE AGREEMENT by and between CERECOR INC. and ALTO NEUROSCIENCE, INC.Patent and Know-How License Agreement • December 28th, 2023 • Alto Neuroscience, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledDecember 28th, 2023 Company Industry JurisdictionTHIS PATENT AND KNOW-HOW LICENSE AGREEMENT (this “Agreement”), effective as of May 28, 2021 (the “Effective Date”), is by and between and Cerecor Inc., a corporation organized and existing under the laws of Delaware (“Cerecor”), and Alto Neuroscience, Inc., a corporation organized and existing under the laws of Delaware (“Licensee”). Cerecor and Licensee are sometimes referred to in this Agreement individually as a “Party” and collectively as the “Parties.”
AMENDED AND RESTATED PATENT AND KNOW-HOW LICENSE AGREEMENTPatent and Know-How License Agreement • February 6th, 2014 • Forest Laboratories Inc • Pharmaceutical preparations • New York
Contract Type FiledFebruary 6th, 2014 Company Industry JurisdictionThis AMENDED AND RESTATED PATENT AND KNOW-HOW LICENSE AGREEMENT (the “Agreement”) dated this 17th day of December, 2013 (the “Restatement Effective Date”) by and between PIERRE FABRE MÉDICAMENT SAS, a corporation organized under the laws of France and having its principal offices at 45, Place Abel Gance 92100 Boulogne - France (“Pierre Fabre”) and FOREST LABORATORIES HOLDINGS LIMITED, a corporation organized under the laws of the Republic of Ireland and having its principal place of business at Cumberland House, 9th Floor, 1 Victoria Street, Hamilton HM 11, Bermuda(“Forest”) a wholly-owned subsidiary of Forest Laboratories, Inc., a Delaware company having its principal offices at 909 Third Avenue, New York, New York 10022.
PATENT AND KNOW-HOW LICENCE AGREEMENTPatent and Know-How License Agreement • December 21st, 2023 • England and Wales
Contract Type FiledDecember 21st, 2023 JurisdictionOn one side, SD Biosensor Inc., a company incorporated under the laws of Republic of Korea, registered at C-4&5Floor, 16, Deogyeong-daero 1556beon-gil, Yeongtong-gu, Suwon-si, Gyeonggi- do, 16690, Republic of Korea (“SDB”).
Patent and know-how licence agreementPatent and Know-How License Agreement • April 12th, 2021 • AST SpaceMobile, Inc. • Communications services, nec
Contract Type FiledApril 12th, 2021 Company IndustryWHEREAS, the Parties entered into a letter agreement dated August 22, 2018 (the “Letter Agreement”) that describes Licensor’s obligation to modify its intellectual property for use by Licensee in the Field of Use (as that term is defined below). Upon Final Acceptance (as that term is defined herein) of such modifications by Licensee in accordance with Section 1(f)(iii) of the Letter Agreement, Licensee agrees to pay Licensor the remaining balance of the Fees (as that term is defined in the Letter Agreement) due thereunder.
SECOND AMENDMENT TO NOVAN PATENT AND KNOW-HOW LICENSE AGREEMENTPatent and Know-How License Agreement • March 27th, 2019 • Novan, Inc. • Pharmaceutical preparations • North Carolina
Contract Type FiledMarch 27th, 2019 Company Industry JurisdictionTHIS SECOND AMENDMENT TO NOVAN PATENT AND KNOW-HOW LICENSE AGREEMENT (this “Second Amendment”) is made as of November 2, 2018 (the “Second Amendment Effective Date”) by and between Novan, Inc., a Delaware corporation with a principal place of business at 4105 Hopson Road, Morrisville, North Carolina 27560 (“Novan”), and KNOW Bio, LLC, a North Carolina limited liability company with a principal place of business at 4222 Emperor Blvd. Suite 470, Durham, NC 27703 (“Licensee”). Novan and Licensee may each be referred to as a “Party,” and together as the “Parties.”
ContractPatent and Know-How License Agreement • September 30th, 2020 • TriplePulse, Inc. • Delaware
Contract Type FiledSeptember 30th, 2020 Company JurisdictionTHIS PATENT AND KNOW-HOW LICENSE AGREEMENT (this "Agreement") is made and entered into this January 15, 2020 (the “Effective Date”) by and between Christopher Thompson, an individual with a principal place of business at 3103 Neilson Way, #D, Santa Monica, CA 90405 ("Licensor") and TriplePulse, Inc., a Delaware corporation with a principal place of business at 1811 Silverside Road, Wilmington, DE, 19810 ("Licensee").
PATENT AND KNOW-HOW LICENCE CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (1) AND COVION ORGANIC SEMICONDUCTORS GMBH (2)Patent and Know-How License Agreement • December 15th, 2004 • Cambridge Display Technology, Inc. • Semiconductors & related devices • England
Contract Type FiledDecember 15th, 2004 Company Industry JurisdictionCONFIDENTIAL TREATMENT REQUESTED: INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED FROM THIS DOCUMENT. SUCH OMISSIONS ARE NOTED BY “[**]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN SUBMITTED SEPARATELY TO THE SECURITIES AND EXCHANGE COMMISSION.
INDEX TO PATENT AND KNOW HOW LICENSE AGREEMENT LSU FILE [***]Patent and Know How License Agreement • November 25th, 2019 • JanOne Inc. • Retail-home furniture, furnishings & equipment stores • Louisiana
Contract Type FiledNovember 25th, 2019 Company Industry JurisdictionThis Agreement is effective as of the First (1st) day of November, 2019 (the "Effective Date"), between JanOne Inc. a corporation incorporated in the State of Nevada, with offices located at 325 East Warm Springs Road, Suite 102, Las Vegas, Nevada, 89119 ("LICENSEE"), and the Board of Supervisors of Louisiana State University and Agricultural and Mechanical College, acting on behalf of LSU Health Sciences Center at Shreveport, a public constitutional corporation, organized and existing under the laws of the State of Louisiana ("LSU ") and the UAB Research Foundation (“UABRF”), a non-profit corporation duly organized and existing under the laws of the State of Alabama, and having its principal office at 701 20th Street South, AB770, Birmingham, AL, 35233 and TheraVasc, Inc, (“TheraVasc”)a Delaware corporation, located in Ohio. In accordance with an Inter-Institutional Agreement, executed on January 10, 2008, with UABRF, LSU will represent UABRF for this license. In accordance with an As
Evgen Pharma plcPatent and Know-How License Agreement • August 2nd, 2023
Contract Type FiledAugust 2nd, 2023company developing sulforaphane-based medicines, and partner JuvLife Ltd, a division of Juvenescence Ltd, have agreed to terminate the Patent and Know-how License Agreement for Evgen's Sulforadex® sulforaphane stabilisation technology.
Patent and Know-How License AgreementPatent and Know-How License Agreement • August 23rd, 2023 • Global Innovative Platforms Inc. • Blank checks • Florida
Contract Type FiledAugust 23rd, 2023 Company Industry JurisdictionThis Patent and Know-How License Agreement (“Agreement”), dated as of August 18, 2023 (the “Effective Date”), is by and between Defiant Technologies Inc., a Delaware corporation, with offices located at 6814 Academy Parkway W NE, Albuquerque, NM, 87109 (“Licensor”), and Global Innovative Platforms Inc., a Delaware corporation, with offices located at 629 Guild Drive, Venice, Florida 34285 (“Licensee”) (collectively, the “Parties,” or each, individually, a “Party”).
ADDENDUM No. 1 to the PATENT AND KNOW-HOW LICENSE AGREEMENT between PIERRE FABRE MEDICAMENT S.A. and NOVACEA, Inc. Dated February 21, 2006Patent and Know-How License Agreement • March 28th, 2006 • Novacea Inc • Pharmaceutical preparations
Contract Type FiledMarch 28th, 2006 Company IndustryThis ADDENDUM No. 1 to the Patent and Know-How License Agreement effective as of February 21, 2006 (the “ADDENDUM No. 1 Effective Date”) is executed by and between PIERRE FABRE MEDICAMENT S.A., a corporation organized under the laws of France with headquarters at 45, place Abel-Gance, 92100 BOULOGNE, FRANCE (“PIERRE FABRE”), and, NOVACEA, INC., a Delaware corporation with a principal place of business at 601 Gateway Boulevard, Suite 800, SOUTH SAN FRANCISCO, CALIFORNIA 94080, U.S.A. (“NOVACEA”).
Exhibit 10.39 CONFIDENTIAL INFORMATION OMITTED AND FILED SEPARATELY WITH SECURITIES AND EXCHANGE COMMISSION ASTERISKS DENOTE SUCH OMISSION AMENDMENT 1 TO THE PATENT AND KNOW HOW LICENSE AGREMENT This Amendment Number 1 to the Patent and Know How...Patent and Know How License Agreement • October 21st, 2002 • Pharmaceutical Resources Inc • Pharmaceutical preparations
Contract Type FiledOctober 21st, 2002 Company IndustryThis Amendment Number 1 to the Patent and Know How Agreement (the "Amendment") is entered into the 24th day of May, 2002 among Nortec Development Associates Inc. and Par Pharmaceutical, Inc.
Patent and Know-how License Agreement – TemplatePatent and Know-How License Agreement • October 18th, 2023
Contract Type FiledOctober 18th, 2023Disclaimer This sample set of legal documents has been made available by the Ministry of Science and Education of the Republic of Croatia for informational purposes only and does not constitute advertising, a solicitation, or legal advice. Neither the transmission of these sample legal documents nor the transmission of any information contained on related websites of the Ministry of Science and Education is intended to create a lawyer-client relationship.